Control Print reports total revenue of Rs 254.26 crores in FY22
EBITDA for the year stood at Rs 60.43 crores, up by 21.3 per cent
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Existing AstraZeneca drug may reduce damage after spinal cord injury
A research, published yesterday in 'Clinical and Translational Medicine,' demonstrated that AZD1236, a drug developed by…
Rutgers pair creates monitoring toolkit to speed production of biologic drugs
Researchers will make the technology free and available to benefit public
PURIFY’22 takes chromatography purification notches higher
Industry rallies around the mega event
Pharma companies with ESG more valuable: Investors at CPhI North America
While it is important for companies to set ESG goals, it is equally important that they measure progress towards them
Glenmark Pharma receives ANDA approval for Abiraterone Acetate tablets USP, 500 mg
The tablets are a generic version of Zytiga Tablets, 500 mg, of Janssen Biotech
Lincoln Pharma reports highest revenue, EBITDA and net profit in FY22
The company reported net profit of Rs 69.36 crores for FY22 as against net profit of Rs 62.25 crores in the corresponding period…
Granules India reports income from operations at Rs 1,030 crores up 29 per cent
YoY, EBITDA at Rs 193 crores, EBITDA margin at 19 per cent; PAT at Rs 111 crores
Lupin releases Q4FY22 results
Basis the long-term outlook, the company's Board has recommended a dividend of 200 per cent
Centrient Pharma announces 100 per cent compliance for clean manufacturing of its oral antibiotic…
The standard covers both Centrient’s sites and its suppliers’ sites